Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
39286 POSTS 0 COMMENTS

April 2020 Briefing – Family Practice

0
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for April 2020. This roundup includes the...

April 2020 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2020. This roundup includes...

April 2020 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2020. This roundup includes the latest...

April 2020 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for April 2020. This roundup includes the latest...

April 2020 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for April 2020. This roundup includes the latest...
In 2019

Incidence of Enteric Infections Due to Pathogens Up or Stable

0
Compared with 2016 to 2018, incidence in 2019 was increased for infections caused by five pathogens
In a cohort of hospitalized adults with COVID-19

Black Patients Overrepresented in Hospitalized COVID-19 Cohort

0
Black patients not more likely to receive invasive mechanical ventilation, die during hospitalization
For patients with COVID-19

Anosmia in COVID-19 Linked to Lower Risk for Admission

0
Pulmonary infiltrates and/or pleural effusion on chest radiograph may increase risk for admission
Contact tracing can reduce the time to case isolation of severe acute respiratory syndrome coronavirus 2

Contact Tracing Can Cut Time to Case Isolation in SARS-CoV-2

0
Household contacts had higher risk for infection; children were as likely to be infected as adults
Use of sodium-glucose cotransporter 2 inhibitors is associated with a reduced risk for serious renal events compared with dipeptidyl peptidase-4 inhibitors

SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events

0
Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors